Tablets "KardiASK": yokusetshenziswa

Medicine "KardiASK" imfundo manual ichaza njengenhlangano agent antiinflammatory, bohlanga imithi non-steroid. Lokhu ukulungiselela yakha umthelela evelele analgesic futhi antipyretic. Ukusebenza kwalesi izidakamizwa eqeda ukuvuvukala kukhona engelapheki Cox okusithiyayo, ngawo thrombus kumiswa kuyehla, platelet wokuhlanganisa futhi adhesion, futhi ivinjiwe kumiswa thromboxane A2.

Iyatholakala izidakamizwa "KardiASK", intengo okuyinto ruble 30-50 ngesimo amaphilisi biconvex emhlophe. Njengoba i-elementi asebenzayo ingaqukatha eyodwa pellet amahlanu noma eziyikhulu amamiligremu angaba acetylsalicylic acid. Iqhaza izithako-accessory isinyathelo plasdon S-630, uhlobo microcrystalline cellulose, uwoyela ocolisekileyo, i-lactose, Tween-80, corn isitashi, propylene glycol, i-calcium stearate, talc futhi plasdon K-90. Titanium dioxide futhi kollikut Mae 100 P sihlanganisa esincane tablet idatha.

Sebenzisa ukulungiselela "KardiASK" imfundo manual khulumela yokwelapha izifo ezifana chorea rheumatism, pericarditis, ne-rheumatoid arthritis. Ukuze esiqoshiwe febrile syndrome, sokucasuka zonke izinhlobo zezifo ezithathelwanayo namakhambi ukuvuvukala, njengoba kukhonjisiwe kulesibonelo aphoyintimenti zomuthi. Ngaphezu kwalokho, ukusetshenziswa le izidakamizwa Kunconywa rheumatism, ikhanda noma ubuhlungu yamazinyo, sokuqaqanjelwa yiqolo, umfutho migraine, neuralgia, myalgia, thoracic radicular syndrome algodismenorei futhi arthralgia. angina engazinzile, ischemia esivimba amanzi futhi isilethikusebenza zifakwe ohlwini izinkomba amaphilisi "KardiASK".

Yokusetshenziswa weluleka ukusebenzisa lolu umuthi nokwelashwa thromboembolism emithambo yegazi, ukuze kuncishiswe ingozi kabusha stenosis futhi yenhliziyo Umthambo izilonda neateroskleroticheskih. Ngaphezu kwalokho, uhlu izinkomba kuhlanganisa ibhaluni angioplasty futhi eziphelayo ischemia palsy, isifo senhliziyo, isifo Takayasu sika, fibrillation atrial, mitral inhliziyo yayo yayinezinkinga ezicini, infarction yamaphaphu futhi ifomu okukhulu thrombophlebitis. Lapho Dressler Syndrome futhi mitral umphini prolapse Kufanele uqale ukuthatha lesi sidakamizwa "KardiASK". Yokusetshenziswa amanothi imiphumela ezinhle elisetshenziswa iziguli kwathiwa unesifo "aspirin triad" noma "aspirin" somoya.

Ukwemukelwa leli thuluzi akuvunyelwe contraindicated kubantu abaphethwe izilonda erosive futhi esidalwa yizilonda emathunjini sibe yokusetshenziswa pheshana emathunjini, von Willebrand isifo, thrombocytopenia, purpura thrombocytopenic noma gipoprotrombinemiey.

Endabeni hypersensitivity kuya acetylsalicylic acid akufanele kuthathwe njengendlela ithebhulethi "KardiASK". Nobufakazi ukukhuluma mayelana undesirability ukusetshenziswa kwabo nomfutho wegazi ophezulu portal, hemophilia, ukuntula vitamin K, telangiectasia, ukwehluleka kwezinso, urate nefrourolitiaze, yokwehluleka kwesibindi nokukhulelwa. C ngokucophelela okukhulu inikezwa izindlela abantu nge sifo, hyperuricemia, isifo sesibindi noma ifomu decompensated ka ezingamahlalakhona yokumelwa yinhliziyo.